Abstract: The use of pharmaceutical compositions comprising at least one antimalarial active substance and an interferon, preferably interferon-gamma (IFN-.gamma.), is disclosed. The pharmaceutical composition according to the invention are used in the treatment of clinical malaria.
Abstract: The present invention involves the inhibition of wound contraction by polypeptides having an amino acid sequence which is similar or identical to certain amino acid sequences of type (I) collagen. A variety of peptides are disclosed which are clinically useful as inhibitors of wound contraction.
Type:
Grant
Filed:
December 20, 1988
Date of Patent:
September 18, 1990
Assignee:
Board of Regents, the University of Texas System